市場調査レポート
商品コード
1298694
小児インターベンショナルカーディオロジー市場:世界の産業動向、シェア、規模、成長機会、2023-2028年予測Pediatric Interventional Cardiology Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028 |
● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。 詳細はお問い合わせください。
小児インターベンショナルカーディオロジー市場:世界の産業動向、シェア、規模、成長機会、2023-2028年予測 |
出版日: 2023年06月14日
発行: IMARC
ページ情報: 英文 136 Pages
納期: 2~3営業日
|
世界の小児インターベンショナルカーディオロジー市場規模は、2022年に25億米ドルに達しました。今後、IMARC Groupは、2023年から2028年にかけて6.5%の成長率(CAGR)を示し、2028年までに37億米ドルに達すると予測しています。
小児インターベンショナル・カーディオロジーは心臓病学の一分野であり、乳幼児、小児、18歳までの青少年の心臓疾患を治療するために特定のカテーテル技術を使用します。バルーン血管形成術,コイル閉塞術,ステント植え込み術,大動脈弁狭窄症などが含まれます。従来の心臓病学的治療と比較して、小児インターベンショナルカーディオロジーは低侵襲であるため、手術後の合併症が少ないです。その結果、血管形成術、弁形成術、冠動脈血栓除去術、先天性心疾患修正術を実施するために、臨床検査機関、病院、心臓センター、研究機関などで幅広く採用されています。
心房中隔欠損症(ASD)、房室管欠損症、動脈管開存症(PDA)、心室中隔欠損症(VSD)など、小児における様々な先天性心疾患の増加傾向は、小児インターベンショナル・カーディオロジー市場の成長を促進する重要な要因の1つです。また、カテーテル、生体吸収性ステント、ガイドワイヤー、バルーン、ステント、血管閉鎖器具、アテレクトミー器具など、新規でより効率的な小児インターベンショナルカーディオロジー器具のイントロダクションも、もう1つの主要な成長促進要因として作用しています。これに伴い、非侵襲的な医療処置に対する患者の傾向の変化や、感染リスクの低下、術後の回復時間の短縮、大きな傷跡の回避など、関連する利点に関する意識の高まりも、市場成長の原動力となっています。その他にも、ヘルスケア支出の増加や、規制手続きの迅速化のために各国政府が行っている数々の取り組みが、市場に明るい見通しをもたらしています。また、広範な研究開発(R&D)活動、消費者のヘルスケア支出の増加、既存のヘルスケア・インフラを強化するための政府や非政府組織(NGO)による投資、心臓病学分野における大幅な技術進歩も市場を牽引しています。
The global pediatric interventional cardiology market size reached US$ 2.5 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 3.7 Billion by 2028, exhibiting a growth rate (CAGR) of 6.5% during 2023-2028.
Pediatric interventional cardiology is a subset of cardiology that involves the use of specific catheter-based techniques to treat heart disorders in infants, children, and adolescents upto 18 years of age. They include balloon angioplasty, coil occlusion, stent implantation, and aortic valve stenosis. As compared to conventional cardiological treatments, pediatric interventional cardiology is more minimally invasive, thus reducing post-surgerycomplications. Consequently, they are extensively employed for performing angioplasty, valvuloplasty, coronary thrombectomy, and congenital heart defect correction procedures across clinical testing laboratories, hospitals, cardiac centers, and research institutes.
Theincreasing instances of various congenital cardiac diseases in children, such as atrial septal defect (ASD), atrioventricular canal defect, patent ductus arteriosus (PDA), and ventricular septal defect (VSD) represent one of the key factors driving the pediatric interventional cardiology market growth. The introduction of novel and more efficient pediatric interventional cardiology devices, including catheters, bio-absorbable stents, guidewires, balloons, stents, vascular closure devices, atherectomy devices is acting as another major growth-inducing factor.In line with this, the shifting inclination of patients toward non-invasive medical treatment procedures, along with the rising awareness regarding the associated benefits, such as lower risk of infection, shorter postoperative recovery times, and avoidance of large scars is also driving the market growth. Other factors, including rising healthcare expenditure and the numerous initiatives being undertaken by governments of various nations to speed-up regulatory procedures, are creating a positive outlook for the market. The market is also driven by extensive research and development (R&D) activities, increasing consumer healthcare expenditure and investments by governments and non-government organizations (NGOs) for strengthening the existing healthcare infrastructure, and significant technological advancements in the field of cardiology.
IMARC Group provides an analysis of the key trends in each sub-segment of the global pediatric interventional cardiology market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on device type, procedure and end use.
Closure Devices
Transcatheter Heart Valves
Atherectomy Devices
Catheters
Balloons
Stents
Others
Catheter-Based Valve Implantation
Congenital Heart Defect Correction
Angioplasty
Coronary Thrombectomy
Others
Clinical Testing Laboratories
Hospitals
Cardiac Centers
Pediatric Clinics
Research Institutions
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
The competitive landscape of the industry has also been examined along with the profiles of the key players being Biotronik SE & Co. KG, Boston Scientific Corporation, Cardinal Health Inc., Edwards Lifesciences Corporation, General Electric Company, Koninklijke Philips N.V., Lepu Medical Technology (Beijing) Co. Ltd., Medtronic plc, NuMED Inc., Siemens Healthineers AG, Terumo Corporation and W. L. Gore & Associates Inc.
Key Questions Answered in This Report
1. What was the size of the global pediatric interventional cardiology market in 2022?
2. What is the expected growth rate of the global pediatric interventional cardiology market during 2023-2028?
3. What are the key factors driving the global pediatric interventional cardiology market?
4. What has been the impact of COVID-19 on the global pediatric interventional cardiology market?
5. What is the breakup of the global pediatric interventional cardiology market based on the device type?
6. What are the key regions in the global pediatric interventional cardiology market?
7. Who are the key players/companies in the global pediatric interventional cardiology market?